Western blotting is a technique widely utilized in biochemistry, immunology and molecular biology for detection and quantification of specific proteins in a given sample of tissue homogenate or extract. It relies on the ability of an antibody to detect its target protein in a mixture of various other proteins known as whole cell or tissue lysate. Western blotting has emerged as the preferred method for protein analysis in various research fields as it enables fast, efficient and sensitive detection of specific proteins from complex mixtures. The global Western Blotting Market is estimated to be valued at US$ 759.05 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing focus on development of therapeutics based on antibody-protein interaction and antibody-based disease detection is a major driver propelling growth of the Western blotting market. Western blotting plays a key role in validation of antibodies used for disease diagnosis and identification of disease biomarkers. It enables researchers to detect the presence, quantity and size of proteins in biological samples from patients. As research in disease pathology and development of antibody-based drugs and diagnostic kits gains momentum, demand for western blotting is witnessing a parallel rise. Growing investments in research studying link between infectious agents and chronic diseases will further contribute to market growth over the forecast period.
SWOT Analysis
Strength: Western blotting provides a sensitive, specific and versatile tool for detecting and analyzing proteins. It is widely used in the research, diagnostic and biopharmaceutical industries.
Weakness: Western blotting is a tedious, time consuming and labor intensive technique that requires special equipment for imaging and analysis. Results can be difficult to interpret depending on the sample being tested.
Opportunity: The demand for western blotting techniques is growing in biomedical research areas like proteomics, cancer research and drug discovery. Advancements in imaging and analysis technologies are automating and simplifying the western blotting workflow.
Threats: Alternative protein detection and analysis methods like ELISA and mass spectrometry are continuously evolving and challenging the dominance of western blotting in some applications. stringent regulations in biosciences also increase compliance costs.
Key Takeaways
The global western blotting market is expected to witness high growth over the forecast period of 2023 to 2030. The market is growing at a CAGR of 6.8% and is projected to reach a value of US$ 759.05 Mn by 2024.
Regional analysis: North America currently dominates the western blotting market owing to robust research funding, presence of leading market players and advanced laboratory infrastructure. Asia Pacific is expected to witness the fastest growth due to rising investments in healthcare and life sciences research in countries like China and India.
Key players: Key players operating in the western blotting market are Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies. These companies are focusing on new product launches, expansion of manufacturing facilities and collaborations to increase their market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it